Recently, research has led to a great success: the effectiveness of our methylene blue plasma pathogen inactivation system on the hepatitis E virus. This study represents valuable knowledge for the health sector, as no other study conducted had such good results! Promoted by our medical affairs and funded by Macopharma, we continue our mission to support life!
Research on pathogen reduction with methylene blue on COVID-19 convalescent plasma immunoglobulin
A recent Spanish clinical study1 responds to concerns about the negative effect of pathogen reduction (PR) with methylene blue (MB) on…
